Global Retirement Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Global Retirement Partners’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$9.14K	Buy	+2,713	New	+$7.04K	﹤0.01%	3195
2024 Q4	$4K	Buy	902 +664	+279%	+$2.69K	﹤0.01%	2786
2024 Q3	$981	Buy	+238	New	+$1.28K	﹤0.01%	3148
2024 Q2	–	Sell	-16	Closed	-$139	–	3593
2024 Q1	$139	Buy	+16	New	+$194	﹤0.01%	3284
2018 Q2	–	Sell	-191	Closed	-$2K	–	1543
2018 Q1	$2K	Hold	191	–	–	﹤0.01%	1342
2017 Q4	$2K	Buy	+191	New	+$2.5K	﹤0.01%	1308

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Global Retirement Partners's IRWD Position: Q4 2025 in Review

Global Retirement Partners opened a new position in Ironwood Pharmaceuticals (IRWD) in Q4 2025: 2,713 shares worth $9.14K. The stake represents ﹤0.01% of the portfolio and ranks #3195 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in IRWD as recently as Q4 2024.

Global Retirement Partners first reported a position in IRWD in Q4 2017 and has held it in 6 quarters since. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2025.

Global Retirement Partners held 2,713 shares of Ironwood Pharmaceuticals worth $9.14K as of Q4 2025.
Ironwood Pharmaceuticals was a new Global Retirement Partners position in Q4 2025.
Ironwood Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3195 holding.
Global Retirement Partners first reported a position in Ironwood Pharmaceuticals in Q4 2017 and has held it in 6 quarters since.
199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.